Back to Search Start Over

Lopinavir/Ritonavir plus nevirapine as a Nucleoside-sparing approach in antiretroviral-experienced patients (NEKA Study)

Authors :
Negredo, Eugenia
Burger, David
Molto, Jose
Cote, Helene
Martinez, Eva
Ribalta, Joseph
Miro, Oscar
Puig, Jordi
Salazar, Juliana
Ruiz, Lidia
Lopez, Sonia
Rey-Joly, Celestino
Montaner, Julio
Clotet, Bonaventura
Source :
Journal of Acquired Immune Deficiency Syndromes (1999). Jan 1, 2005, Vol. 38 Issue 1, p47, 6 p.
Publication Year :
2005

Abstract

A study is made to compare the efficacy and safety of a nucleoside sparing approach with a conventional highly active antiretroviral therapy (HAART) regimen in antiretroviral-experienced patients with prolonged viral suppression. The result showed that all patients maintained viral suppression after 48 weeks and no subject discontinued therapy because of adverse events.

Details

Language :
English
ISSN :
15254135
Volume :
38
Issue :
1
Database :
Gale General OneFile
Journal :
Journal of Acquired Immune Deficiency Syndromes (1999)
Publication Type :
Academic Journal
Accession number :
edsgcl.132105703